These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28385775)

  • 1. Variant
    Dowse RT; Ireland RM
    Blood; 2017 Apr; 129(14):2038. PubMed ID: 28385775
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of acute promyelocytic leukaemia with unusual cytological features and a ZBTB16-RARA fusion gene.
    Lechevalier N; Dulucq S; Bidet A
    Br J Haematol; 2016 Aug; 174(4):502. PubMed ID: 27302179
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia.
    Fabiani E; Cicconi L; Nardozza AM; Cristiano A; Rossi M; Ottone T; Falconi G; Divona M; Testi AM; Annibali O; Castelli R; Lazarevic V; Rego E; Montesinos P; Esteve J; Venditti A; Della Porta M; Arcese W; Lo-Coco F; Voso MT
    Cancer Med; 2021 Jun; 10(12):3839-3847. PubMed ID: 34042280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful allogeneic bone marrow transplantation in a case of variant acute promyelocytic leukemia with ZBTB16-RARA.
    Morimoto S; Kondo T; Taya T; Matsuo H; Teramoto Y; Mizumoto C; Kanda J; Yamashita K; Takaori-Kondo A
    Ann Hematol; 2022 May; 101(5):1129-1132. PubMed ID: 35347397
    [No Abstract]   [Full Text] [Related]  

  • 5. Differentiation therapy using low-dose venetoclax in a variant acute promyelocytic leukaemia carrying ZBTB16-RARA.
    Li H; Xiang X; Ding H; Yu J; Xu J; Yuan Y; Wu Y
    Br J Haematol; 2022 Dec; 199(5):768-771. PubMed ID: 36169236
    [No Abstract]   [Full Text] [Related]  

  • 6. ZBTB16-RARα-Positive Atypical Promyelocytic Leukemia: A Case Report.
    Pardo Gambarte L; Franganillo Suárez A; Cornago Navascués J; Soto de Ozaeta C; Blas López C; Atance Pasarisas M; Salgado Sánchez RN; Serrano Del Castillo C; Mata Serna R; Velasco Rodríguez D; López-Lorenzo JL; Llamas-Sillero P; Solán Blanco L
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of variant APL translocations PRKAR1A-RARα and ZBTB16-RARα (PLZF-RARα) through the MI-ONCOSEQ platform.
    King D; Foucar CE; Ma V; Benitez L; Perissinotti AJ; Marini BL; Robinson D; Bhave RR; Bixby D
    Cancer Genet; 2021 Nov; 258-259():57-60. PubMed ID: 34534739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Round Promyelocyte Cells with Round Nuclei: Clues to the Diagnosis of
    Su Y; Zhao J; Fan X; Yang W; Liu J
    Turk J Haematol; 2023 Dec; 40(4):273-274. PubMed ID: 37314303
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent
    Osumi T; Tsujimoto SI; Tamura M; Uchiyama M; Nakabayashi K; Okamura K; Yoshida M; Tomizawa D; Watanabe A; Takahashi H; Hori T; Yamamoto S; Hamamoto K; Migita M; Ogata-Kawata H; Uchiyama T; Kizawa H; Ueno-Yokohata H; Shirai R; Seki M; Ohki K; Takita J; Inukai T; Ogawa S; Kitamura T; Matsumoto K; Hata K; Kiyokawa N; Goyama S; Kato M
    Cancer Res; 2018 Aug; 78(16):4452-4458. PubMed ID: 29921692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Promyelocytic Leukemia: A Review and Discussion of Variant Translocations.
    Adams J; Nassiri M
    Arch Pathol Lab Med; 2015 Oct; 139(10):1308-13. PubMed ID: 26414475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia.
    Zhao J; Liang JW; Xue HL; Shen SH; Chen J; Tang YJ; Yu LS; Liang HH; Gu LJ; Tang JY; Li BS
    Leukemia; 2019 Jun; 33(6):1387-1399. PubMed ID: 30575821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel recurrent
    Yao L; Wen L; Wang N; Liu T; Xu Y; Ruan C; Wu D; Chen S
    Blood; 2018 Feb; 131(8):935-939. PubMed ID: 29237593
    [No Abstract]   [Full Text] [Related]  

  • 13. Microfluidic-Based Detection of AML-Specific Biomarkers Using the Example of Promyelocyte Leukemia.
    Emde B; Kreher H; Bäumer N; Bäumer S; Bouwes D; Tickenbrock L
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The leukemic oncoprotein NPM1-RARA inhibits TP53 activity.
    Swaney EM; Chattopadhyay A; Abecassis I; Rush EA; Redner RL
    Leuk Lymphoma; 2016 Aug; 57(8):1933-7. PubMed ID: 26754533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report of IRF2BP1 as a novel partner of RARA in variant acute promyelocytic leukemia.
    Jiang M; Wang X; Yu M; Jiang S; Hong M; Zhou Y; Li F; Liu H; Zhang Z
    Am J Hematol; 2024 May; 99(5):1005-1007. PubMed ID: 38410879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FNDC3B is another novel partner fused to RARA in the t(3;17)(q26;q21) variant of acute promyelocytic leukemia.
    Cheng CK; Wang AZ; Wong THY; Wan TSK; Cheung JS; Raghupathy R; Chan NPH; Ng MHL
    Blood; 2017 May; 129(19):2705-2709. PubMed ID: 28314734
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute promyelocytic leukemia with a cryptic insertion of RARA into TBL1XR1.
    Osumi T; Watanabe A; Okamura K; Nakabayashi K; Yoshida M; Tsujimoto SI; Uchiyama M; Takahashi H; Tomizawa D; Hata K; Kiyokawa N; Kato M
    Genes Chromosomes Cancer; 2019 Nov; 58(11):820-823. PubMed ID: 31350930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia.
    Iaccarino L; Divona M; Ottone T; Cicconi L; Lavorgna S; Ciardi C; Alfonso V; Travaglini S; Facchini L; Cimino G; Di Bona E; Voso MT; Lo-Coco F
    Genes Chromosomes Cancer; 2019 Jan; 58(1):60-65. PubMed ID: 30421475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute promyelocytic leukaemia (APML) with cryptic PML-RARA fusion has a clinical course comparable to classical APML with t(15;17)(q24.1;q21.2) translocation.
    Greenfield G; Michail O; Merron B; McGimpsey J; Catherwood M; McMullin MF
    Br J Haematol; 2019 Jul; 186(1):155-157. PubMed ID: 30585303
    [No Abstract]   [Full Text] [Related]  

  • 20. IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.
    Mazharuddin S; Chattopadhyay A; Levy MY; Redner RL
    Leuk Lymphoma; 2018 Sep; 59(9):2246-2249. PubMed ID: 29350080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.